Loring Wolcott & Coolidge Fiduciary Advisors’s Ocular Therapeutix OCUL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-20,000	Closed	-$79K	–	746
2019 Q1	$79K	Buy	20,000 +10,000	+100%	+$39.5K	﹤0.01%	356
2018 Q4	$40K	Buy	+10,000	New	+$40K	﹤0.01%	437